부산대학교 도서관

Cost-effectiveness analysis of an active search to retrieve HCV patients lost to follow-up (RELINK-C strategy) and the impact of COVID-19 Keywords: cost-effectiveness analysis; COVID-19 pandemic; hepatitis C elimination; linkage to care; lost to follow-up patients EN cost-effectiveness analysis COVID-19 pandemic hepatitis C elimination linkage to care lost to follow-up patients 579 583 5 06/10/22 20220701 NES 220701 Abbreviations ALT Alanine Aminotransferase AST Aspartate Aminotransferase DAA direct-acting antivirals HCV Hepatitis C virus LTFU Lost to follow-up RNA Ribonucleic acid INTRODUCTION Hepatitis C virus (HCV) infection affects 71 million people worldwide. Cost-effectiveness analysis, lost to follow-up patients, COVID-19 pandemic, hepatitis C elimination, linkage to care A higher percentage of patients was located (65% vs 62%) among candidates to contact during the COVID-19 pandemic, and a larger number of patients located attended the physician's appointment (88% vs 41%) than during pre-COVID-19. [Extracted from the article]